These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 27085727)
1. Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis. Kyvernitakis A; Torres HA; Jiang Y; Chamilos G; Lewis RE; Kontoyiannis DP Clin Microbiol Infect; 2016 Sep; 22(9):811.e1-811.e8. PubMed ID: 27085727 [TBL] [Abstract][Full Text] [Related]
2. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries. Pana ZD; Seidel D; Skiada A; Groll AH; Petrikkos G; Cornely OA; Roilides E; BMC Infect Dis; 2016 Nov; 16(1):667. PubMed ID: 27832748 [TBL] [Abstract][Full Text] [Related]
3. Mortality in hematologic malignancy and hematopoietic stem cell transplant patients with mucormycosis, 2001 to 2009. Hammond SP; Baden LR; Marty FM Antimicrob Agents Chemother; 2011 Nov; 55(11):5018-21. PubMed ID: 21876046 [TBL] [Abstract][Full Text] [Related]
4. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study. Bird GT; Farquhar-Smith P; Wigmore T; Potter M; Gruber PC Br J Anaesth; 2012 Mar; 108(3):452-9. PubMed ID: 22298243 [TBL] [Abstract][Full Text] [Related]
5. Mucormycoses in patients with hematologic malignancies: an emerging fungal infection. Bethge WA; Schmalzing M; Stuhler G; Schumacher U; Kröber SM; Horger M; Einsele H; Kanz L; Hebart H Haematologica; 2005 Nov; 90 Suppl():ECR22. PubMed ID: 16266913 [TBL] [Abstract][Full Text] [Related]
7. Mucormycosis-associated fungal infections in patients with haematologic malignancies. Kara IO; Tasova Y; Uguz A; Sahin B Int J Clin Pract; 2009 Jan; 63(1):134-9. PubMed ID: 17362481 [TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics, Prognosis Factors and Metagenomic Next-Generation Sequencing Diagnosis of Mucormycosis in patients With Hematologic Diseases. Wang J; Liu L; Li J; Feng X; Yi H; Jiang E; Zheng Y; Zhang F; Zhu X; Mi Y; Han M; Wang J; Feng S Mycopathologia; 2024 Aug; 189(4):71. PubMed ID: 39088077 [TBL] [Abstract][Full Text] [Related]
9. Mucormycosis in hematologic patients. Pagano L; Offidani M; Fianchi L; Nosari A; Candoni A; Picardi M; Corvatta L; D'Antonio D; Girmenia C; Martino P; Del Favero A; Haematologica; 2004 Feb; 89(2):207-14. PubMed ID: 15003897 [TBL] [Abstract][Full Text] [Related]
10. Delaying diagnostic procedure significantly increases mortality in patients with invasive mucormycosis. Jeong SJ; Lee JU; Song YG; Lee KH; Lee MJ Mycoses; 2015 Dec; 58(12):746-52. PubMed ID: 26565066 [TBL] [Abstract][Full Text] [Related]
11. Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports. Jeong W; Keighley C; Wolfe R; Lee WL; Slavin MA; Chen SC; Kong DCM Int J Antimicrob Agents; 2019 May; 53(5):589-597. PubMed ID: 30639526 [TBL] [Abstract][Full Text] [Related]
12. Invasive pulmonary aspergillosis: comparative analysis in cancer patients with underlying haematologic malignancies versus solid tumours. Dib RW; Khalil M; Fares J; Hachem RY; Jiang Y; Dandachi D; Chaftari AM; Raad II J Hosp Infect; 2020 Mar; 104(3):358-364. PubMed ID: 31585141 [TBL] [Abstract][Full Text] [Related]
13. Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008). Xhaard A; Lanternier F; Porcher R; Dannaoui E; Bergeron A; Clement L; Lacroix C; Herbrecht R; Legrand F; Mohty M; Michallet M; Cordonnier C; Malak S; Guyotat D; Couderc LJ; Socié G; Milpied N; Lortholary O; Ribaud P Clin Microbiol Infect; 2012 Oct; 18(10):E396-400. PubMed ID: 22672535 [TBL] [Abstract][Full Text] [Related]
14. Pediatric Mucormycosis: A 10-Year Systematic Review of Reported Cases and Review of the Literature. Otto WR; Pahud BA; Yin DE J Pediatric Infect Dis Soc; 2019 Sep; 8(4):342-350. PubMed ID: 31181136 [TBL] [Abstract][Full Text] [Related]
16. Mucormycosis: a new concern in the transplant ward? Robin C; Alanio A; Cordonnier C Curr Opin Hematol; 2014 Nov; 21(6):482-90. PubMed ID: 25295745 [TBL] [Abstract][Full Text] [Related]
17. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies. Raad II; Zakhem AE; Helou GE; Jiang Y; Kontoyiannis DP; Hachem R Int J Antimicrob Agents; 2015 Mar; 45(3):283-8. PubMed ID: 25455847 [TBL] [Abstract][Full Text] [Related]
18. Mucormycosis in Children With Hematologic Malignancies: A Case Series and Review of the Literature. Loeffen YGT; Scharloo F; Goemans BF; Heitink-Polle KMJ; Lindemans CA; van der Bruggen T; Hagen F; Wolfs TFW Pediatr Infect Dis J; 2022 Sep; 41(9):e369-e376. PubMed ID: 35703287 [TBL] [Abstract][Full Text] [Related]
19. Survival of patients with hematological malignancy admitted to the intensive care unit: prognostic factors and outcome compared to unselected medical intensive care unit admissions, a parallel group study. Hill QA; Kelly RJ; Patalappa C; Whittle AM; Scally AJ; Hughes A; Ashcroft AJ; Hill A Leuk Lymphoma; 2012 Feb; 53(2):282-8. PubMed ID: 21846185 [TBL] [Abstract][Full Text] [Related]